Cargando…

2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer

Breast cancer (BC) is the most common cancer in women. Estrogen, epidermal growth factor receptor 2 (ERBB2, HER2), and oxidative stress represent critical mechanistic nodes associated with BC. RLIP76 is a major mercapturic acid pathway transporter whose expression is increased in BC. In the quest of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagaprashantha, Lokesh Dalasanur, Singhal, Jyotsana, Li, Hongzhi, Warden, Charles, Liu, Xueli, Horne, David, Awasthi, Sanjay, Salgia, Ravi, Singhal, Sharad S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915057/ https://www.ncbi.nlm.nih.gov/pubmed/29719590 http://dx.doi.org/10.18632/oncotarget.24720

Ejemplares similares

Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2022)

RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer
por: Leake, Kathryn, et al.
Publicado: (2012)

RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
por: Singhal, Jyotsana, et al.
Publicado: (2011)

2'-Hydroxyflavanone: A novel strategy for targeting breast cancer
por: Singhal, Jyotsana, et al.
Publicado: (2017)

Anticancer activity of 2’-hydroxyflavanone towards lung cancer
por: Awasthi, Sanjay, et al.
Publicado: (2018)

A Central Role of RLIP76 in Regulation of Glycemic Control
por: Awasthi, Sanjay, et al.
Publicado: (2010)

RLIP76, a non-ABC transporter, and drug resistance in epilepsy
por: Awasthi, Sanjay, et al.
Publicado: (2005)

Proteomic Analysis of Signaling Network Regulation in Renal Cell Carcinomas with Differential Hypoxia-Inducible Factor-2α Expression
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2013)

Rlip depletion prevents spontaneous neoplasia in TP53 null mice
por: Awasthi, Sanjay, et al.
Publicado: (2018)

Rlip Depletion Suppresses Growth of Breast Cancer
por: Bose, Chhanda, et al.
Publicado: (2020)

Topical 2′-Hydroxyflavanone for Cutaneous Melanoma
por: Bose, Chhanda, et al.
Publicado: (2019)

Didymin: an orally active citrus flavonoid for targeting neuroblastoma
por: Singhal, Sharad S., et al.
Publicado: (2017)

Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
por: Goldfinger, Lawrence E, et al.
Publicado: (2013)

RLIP76: A Structural and Functional Triumvirate
por: Cornish, Jasmine, et al.
Publicado: (2021)

Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
por: Hindle, Ashly, et al.
Publicado: (2022)

Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence
por: Fan, Song-Yuan, et al.
Publicado: (2015)

A potential function of RLIP76 in the ovarian corpus luteum
por: Billhaq, Dody Houston, et al.
Publicado: (2019)

Association of TGF-β1 Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case–Control Studies †
por: Krishna, B. Madhu, et al.
Publicado: (2020)

Rlip Protein: A Potential Target for COVID-19
por: Kopel, Jonathan, et al.
Publicado: (2022)

Headliners: Cancer: Inhibition of RLIP76 Causes Complete Regression of Melanoma in Mice
por: Phelps, Jerry
Publicado: (2006)

RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients
por: Manguoğlu, E, et al.
Publicado: (2011)

Microbial Transformations of 7-Hydroxyflavanone
por: Kostrzewa-Susłow, Edyta, et al.
Publicado: (2012)

RLIP76 decreases apoptosis through Akt/mTOR signaling pathway in gastric cancer
por: Wang, Wenwen, et al.
Publicado: (2018)

RLIP76 decreases apoptosis through Akt/mTOR signaling pathway in gastric cancer
por: Wang, Wenwen, et al.
Publicado: (2016)

Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
por: Hindle, Ashly, et al.
Publicado: (2022)

Increased RLIP76 expression in IDH1 wild-type glioblastoma multiforme is associated with worse prognosis
por: Wang, Qi, et al.
Publicado: (2020)

Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells
por: Bennani-Baiti, Barbara, et al.
Publicado: (2015)

Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases
por: Hurd, Catherine A., et al.
Publicado: (2020)

RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration
por: Goldfinger, Lawrence E., et al.
Publicado: (2006)

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas
por: Figarola, James L., et al.
Publicado: (2018)

Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone
por: Akbar, Shehla, et al.
Publicado: (2023)

Doxorubicin-Induced Cardiomyopathy: A Preliminary Study on the Cardioprotective Benefits of 7-Hydroxyflavanone
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2023)

The Structure of the RLIP76 RhoGAP-Ral Binding Domain Dyad: Fixed Position of the Domains Leads to Dual Engagement of Small G Proteins at the Membrane
por: Rajasekar, Karthik V., et al.
Publicado: (2013)

COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice
por: Figarola, James Lester, et al.
Publicado: (2013)

2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis
por: Gervazoni, Luiza F. O., et al.
Publicado: (2018)

Efficacy of 2-Hydroxyflavanone in Rodent Models of Pain and Inflammation: Involvement of Opioidergic and GABAergic Anti-Nociceptive Mechanisms
por: Khan, Faiz Ali, et al.
Publicado: (2022)

Analysis of 2′-hydroxyflavanone (2HF) in mouse whole blood by HPLC–MS/MS for the determination of pharmacokinetic parameters
por: Gervazoni, Luiza F. O., et al.
Publicado: (2023)

Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
por: Singh, Sharda P., et al.
Publicado: (2021)

Identification and Characterization of the RLIP/RALBP1 Interacting Protein Xreps1 in Xenopus laevis Early Development
por: Boissel, Laurent, et al.
Publicado: (2012)

Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish
por: Singhal, Sharad S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_51tpd1a0b9f16aa12qk86cqj4f